Higher fibrotic content of endometriotic lesions is associated with diminished prostaglandin E2 signaling
article
OA: gold
CC0
⤵ 20 in-corpus citations
AI-generated summary
Endometriotic lesions with higher fibrotic content showed reduced COX-2, EP2, and EP4 expression, indicating diminished prostaglandin E2 signaling as fibrosis increases.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Abstract Purpose While the prevailing view holds that the prostaglandin E2 (PGE 2 ) signaling plays a vital role in endometriosis, PGE 2 also is known to be anti‐fibrotic. We investigated the immunostaining of COX‐2, EP2, and EP4, along with fibrotic content in ovarian endometrioma (OE) and deep endometriosis (DE) lesions, and in OE lesions from adolescent and adult patients. In addition, we evaluated the effect of substrate stiffness on the expression of COX‐2, EP2, and EP4 in endometrial stromal cells. Methods Immunohistochemistry analysis of COX‐2, EP2, and EP4, along with the quantification of lesional fibrosis, was conducted for OE and DE lesion samples and also OE lesion samples from adolescent and adult patients. The effect of substrate rigidity on fibroblast‐to‐myofibroblast transdifferentiation (FMT) and the expression of COX‐2, EP2, and EP4, with or without TGF‐β1 stimulation, were investigated. Results The immunostaining of COX‐2, EP2, and EP4 was substantially reduced in endometriotic lesions as lesions became more fibrotic. Both TGF‐β1 stimulation and stiff substrates induced FMT and reduced the expression of COX‐2, EP2, and EP4. Conclusions Since fibrosis is a common feature of endometriosis, our results thus cast doubts on the use of therapeutics that suppresses the PGE 2 signaling pathway, either by inhibiting COX‐2 or EP2/EP4.
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (92)
- Abnormal Expression of Prostaglandins E2 and F2<i>α</i>Receptors and Transporters in Patients with Endometriosis via openalex
- Absence of aromatase protein and mRNA expression in endometriosis via openalex
- ACOG Committee Opinion No. 760: Dysmenorrhea and Endometriosis in the Adolescent via openalex
- Analysis of cyclooxygenase-2 (COX-2) expression in different sites of endometriosis and correlation with clinico-pathological parameters via openalex
- An Analysis of <i>ESR2</i> and <i>CYP19A1</i> Gene Expression Levels in Women With Endometriosis via openalex
- Aromatase in endometriosis and uterine leiomyomata via openalex
- A selective cyclooxygenase-2 inhibitor suppresses the growth of endometriosis xenografts via antiangiogenic activity in severe combined immunodeficiency mice via openalex
- Cellular Changes Consistent With Epithelial–Mesenchymal Transition and Fibroblast-to-Myofibroblast Transdifferentiation in the Progression of Experimental Endometriosis in Baboons via openalex
- Chronic stress accelerates the development of endometriosis in mouse through adrenergic receptor β<sub>2</sub> via openalex
- COX-2 overexpression in peritoneal lesions is correlated with nonmenstrual chronic pelvic pain via openalex
- Cyclooxygenase-2 expression in deep endometriosis and matched eutopic endometrium via openalex
- Cyclooxygenase-2 in Endometriosis via openalex
- Delay in the diagnosis of endometriosis: a survey of women from the USA and the UK via openalex
- Diagnosing Deep Endometriosis Using Transvaginal Elastosonography via openalex
- Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis via openalex
- Effect of oral contraceptives on vascular endothelial growth factor, Cox-2 and aromatase expression in the endometrium of uteri affected by myomas and associated pathologies via openalex
- Effects of matrix stiffness on epithelial to mesenchymal transition-like processes of endometrial epithelial cells: Implications for the pathogenesis of endometriosis via openalex
- Evidence in Support for the Progressive Nature of Ovarian Endometriomas via openalex
- Fibrogenesis resulting from cyclic bleeding: the Holy Grail of the natural history of ectopic endometrium via openalex
- Fibromuscular differentiation in deeply infiltrating endometriosis is a reaction of resident fibroblasts to the presence of ectopic endometrium via openalex
- Higher fibrotic content of endometriotic lesions is associated with diminished prostaglandin E2 signaling via openalex
- Histological and Immunohistochemical Characterization of the Similarity and Difference Between Ovarian Endometriomas and Deep Infiltrating Endometriosis via openalex
- Hormonal Therapy Deregulates Prostaglandin-Endoperoxidase Synthase 2 (<i>PTGS2</i>) Expression in Endometriotic Tissues via openalex
- Hypoxia‐inhibited dual‐specificity phosphatase‐2 expression in endometriotic cells regulates cyclooxygenase‐2 expression via openalex
- Identification of multiple and distinct defects in prostaglandin biosynthetic pathways in eutopic and ectopic endometrium of women with endometriosis via openalex
- Implication of the RAGE–EN‐RAGE axis in endometriosis via openalex
- Increased cyclooxygenase-2 expression is associated with better clinical outcome in patients submitted to complete ablation for severe endometriosis via openalex
- Increased Production of 17β-Estradiol in Endometriosis Lesions Is the Result of Impaired Metabolism via openalex
- Induction of peritoneal endometriosis in nude mice with use of human immortalized endometriosis epithelial and stromal cells: a potential experimental tool to study molecular pathogenesis of endometriosis in humans via openalex
- Leptin, its receptor and aromatase expression in deep infiltrating endometriosis via openalex
- Metformin Suppresses Prostaglandin E2-Induced Cytochrome P450 Aromatase Gene Expression and Activity via Stimulation of AMP-Activated Protein Kinase in Human Endometriotic Stromal Cells via openalex
- Molecular and preclinical basis to inhibit PGE <sub>2</sub> receptors EP2 and EP4 as a novel nonsteroidal therapy for endometriosis via openalex
- Neuropeptides Substance P and Calcitonin Gene Related Peptide Accelerate the Development and Fibrogenesis of Endometriosis via openalex
- Nonsteroidal antiinflammatory drugs differentially suppress endometriosis in a murine model via openalex
- Physiology of the Endometrium and Regulation of Menstruation via openalex
- Platelets drive smooth muscle metaplasia and fibrogenesis in endometriosis through epithelial–mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation via openalex
- Popularity of endocrine endometriosis drugs and limited alternatives in the present and foreseeable future: A survey among 1420 affected women via openalex
- Progressive development of endometriosis and its hindrance by anti-platelet treatment in mice with induced endometriosis via openalex
- Progressive Fibrosis: A Progesterone- and KLF11-Mediated Sexually Dimorphic Female Response via openalex
- Prostaglandin E2 Stimulates Aromatase Expression in Endometriosis-Derived Stromal Cells via openalex
- Prostaglandin E<sub>2</sub>Stimulates Aromatase Expression in Endometriosis-Derived Stromal Cells<sup>1</sup> via openalex
- Prostaglandin E <sub>2</sub> : the master of endometriosis? via openalex
- Regulation of Aromatase P450 Expression in Endometriotic and Endometrial Stromal Cells by CCAAT/Enhancer Binding Proteins (C/EBPs): Decreased C/EBPβ in Endometriosis Is Associated with Overexpression of Aromatase via openalex
- Regulation of Steroidogenic Acute Regulatory Protein Expression and Progesterone Production in Endometriotic Stromal Cells via openalex
- Selective Inhibition of Prostaglandin E2 Receptors EP2 and EP4 Inhibits Adhesion of Human Endometriotic Epithelial and Stromal Cells Through Suppression of Integrin-Mediated Mechanisms1 via openalex
- Selective inhibition of prostaglandin E2 receptors EP2 and EP4 modulates DNA methylation and histone modification machinery proteins in human endometriotic cells via openalex
- Smooth muscles are frequent components of endometriotic lesions via openalex
- The potential danger of COX-2 inhibitors via openalex
- The role of prostaglandin E <sub>2</sub> in endometriosis via openalex
- Time to redefine endometriosis including its pro-fibrotic nature via openalex
- Up-Regulation of Cyclooxygenase-2 Expression and Prostaglandin E2 Production in Human Endometriotic Cells by Macrophage Migration Inhibitory Factor: Involvement of Novel Kinase Signaling Pathways via openalex
- Use of selective PGE2 receptor antagonists on human endometriotic stromal cells and peritoneal macrophages via openalex
- Value of ultrasound shear wave elastography in the diagnosis of adenomyosis via openalex
- W3012503461 via openalex
- W1495075494 via openalex
- W1710016801 via openalex
- W1795803543 via openalex
- W1969169755 via openalex
- W1978158142 via openalex
- W1995721099 via openalex
- W2016980021 via openalex
- W2031938767 via openalex
- W2036462978 via openalex
- W2039274017 via openalex
- W2049019160 via openalex
- W2050189717 via openalex
- W2051479586 via openalex
- W2054034692 via openalex
- W2071716296 via openalex
- W2109525253 via openalex
- W2109801386 via openalex
- W2116043657 via openalex
- W2120736394 via openalex
- W2120857280 via openalex
- W2121612337 via openalex
- W2126853519 via openalex
- W2133907923 via openalex
- W2159223559 via openalex
- W2159731793 via openalex
- W2166735590 via openalex
- W2171169752 via openalex
- W2172237567 via openalex
- W2770742412 via openalex
- W2781934183 via openalex
- W2900848106 via openalex
- W2912352885 via openalex
- W2916649801 via openalex
- W2991998568 via openalex
- W78459228 via openalex
- W3015240719 via openalex
- W3077010215 via openalex
- W3085048027 via openalex
Cited by (20)
- Hormonal Dysregulation and Neuroinflammation in Endometriosis: Convergent Druggable Pathways 2026
- Progressively diminished estrogen signaling concordant with increased fibrosis in ectopic endometrium 2025
- Assessment of Al18F-NOTA-FAPI-04 PET/CT imaging for visualization and localization of ovarian and peritoneal endometriotic lesions in a rat model 2025
- Drug development for adenomyosis based on pathophysiology 2025
- Patterns of proliferation and fibrosis in a rat model of endometriosis following administration of Allium cepa 2024
- The role of fibrosis in endometriosis: a systematic review 2024
- Progressively Diminished Prostaglandin E2 Signaling in Concordance with Increasing Fibrosis in Ectopic Endometrium 2024
- Systematic review and meta-analysis of reproductive outcomes after high-intensity focused ultrasound (HIFU) treatment of adenomyosis 2023
- Corroborating evidence for aberrant expression of histone deacetylase 8 in endometriosis 2023
- Digestive system deep infiltrating endometriosis: What do we know 2023
- In the thicket of fears, doubts, and murky facts: some reflections on treatment modalities for endometriosis-associated pain 2023
- Aberrant expression of histone deacetylase 8 in endometriosis and its potential as a therapeutic target 2023
- The Role of Platelets in the Pathogenesis and Pathophysiology of Adenomyosis 2023
- Cracking the enigma of adenomyosis: an update on its pathogenesis and pathophysiology 2022
- Endometriosis, the Silent Disease: Molecular Targets, Active Principles, and Drug Delivery Systems 2022
- Age‐dependent phenotypes of ovarian endometriomas 2022
- Decreased Glycolysis at Menstruation is Associated with Increased Menstrual Blood Loss 2022
- How does the extent of fibrosis in adenomyosis lesions contribute to heavy menstrual bleeding? 2022
- Higher fibrotic content of endometriotic lesions is associated with diminished prostaglandin E2 signaling 2021
- Changing prostaglandin E2 (PGE<sub>2</sub>) signaling during lesional progression and exacerbation of endometriosis by inhibition of PGE<sub>2</sub> receptor EP2 and EP4 2021
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:24:03.506079+00:00
License: CC0
· commercial use OK